Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Diana Canetti
Observed names:
Canetti, Diana,
D Canetti,
D. Canetti
Institutions:
Vita-Salute San Raffaele University,
IRCCS Ospedale San Raffaele,
IRCCS San Raffaele Roma
Observed institutions:
University of Parma,
Vita-Salute San Raffaele University,
Azienda Ospedaliera Universitaria Integrata Verona,
Ospedale G.B. Morgagni - L.Pierantoni,
IRCCS Ospedale San Raffaele,
Ospedale di Parma,
IRCCS San Raffaele Roma
show all 7
ORCID:
0000-0002-7962-7193
Observed ORCID:
0000-0002-7962-7193
OpenAlex ID:
A5039581504
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
2020
·
Giulio Cavalli
, Giacomo De Luca
, et al.
·
The Lancet Rheumatology
·
1,036
PDF
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
2020
·
Marco Ripa
, Laura Galli
, et al.
·
Clinical Microbiology and Infection
·
393
PDF
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC
2018
·
Giulia Mazzaschi
, Francesco Facchinetti
, et al.
·
Lung Cancer
·
133
Candidemia in Coronavirus Disease 2019 (COVID-19) Patients: Incidence and Characteristics in a Prospective Cohort Compared With Historical Non–COVID-19 Controls
2020
·
Andrea Mastrangelo
, Bruno Nicolò Germinario
, et al.
·
Clinical Infectious Diseases
·
126
Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis
2012
·
Amalia Penna
, Diletta Laccabue
, et al.
·
Journal of Hepatology
·
93
Mycobacterium marinum: A brief update for clinical purposes
2022
·
Diana Canetti
, Niccolò Riccardi
, et al.
·
European Journal of Internal Medicine
·
69
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19
2020
·
V. Spagnuolo
, M. Guffanti
, et al.
·
Scientific Reports
·
64
PDF
Tuberculosis and pharmacological interactions: A narrative review
2020
·
Niccolò Riccardi
, Diana Canetti
, et al.
·
Current Research in Pharmacology and Drug Discovery
·
56
PDF
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO Registry
2020
·
Laura Galli
, Maria Rita Parisi
, et al.
·
Open Forum Infectious Diseases
·
54
PDF
Monkeypox infection among men who have sex with men: PCR testing on seminal fluids
2022
·
Angelo Roberto Raccagni
, Caterina Candela
, et al.
·
Journal of Infection
·
53
PDF
Delay in schistosomiasis diagnosis and treatment: a multicenter cohort study in Italy
2019
·
Agnese Comelli
, Niccolò Riccardi
, et al.
·
Journal of Travel Medicine
·
46
Two individuals with potential monkeypox virus reinfection
2023
·
Angelo Roberto Raccagni
, Diana Canetti
, et al.
·
The Lancet Infectious Diseases
·
43
PDF
HIV and tuberculosis: A historical perspective on conflicts and challenges
2020
·
Diana Canetti
, Niccolò Riccardi
, et al.
·
Tuberculosis
·
43
Real‐life use of cidofovir for the treatment of severe monkeypox cases
2022
·
Angelo Roberto Raccagni
, Caterina Candela
, et al.
·
Journal of Medical Virology
·
42
PDF
Infections in lung transplanted patients: A review
2022
·
M. Dettori
, N. Riccardi
, et al.
·
Pulmonology
·
40
PDF
Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics
2023
·
Caterina Candela
, Angelo Roberto Raccagni
, et al.
·
Viruses
·
34
PDF
Monkeypox and pan-resistant Campylobacter spp infection in Entamoeba histolytica and Chlamydia trachomatis re-infection in a man who have sex with men
2022
·
Angelo Roberto Raccagni
, Davide Mileto
, et al.
·
Journal of Infection
·
34
Clofazimine: An Old Drug for Never-Ending Diseases
2020
·
Niccolò Riccardi
, Andrea Giacomelli
, et al.
·
Future Microbiology
·
34
Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma
2020
·
Alessandra Zecca
, Valeria Barili
, et al.
·
Cancer Immunology Immunotherapy
·
31
One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study
2024
·
Camilla Muccini
, Nicola Gianotti
, et al.
·
Open Forum Infectious Diseases
·
30
Breakthrough monkeypox infection among individuals previously immunized with smallpox or monkeypox vaccination
2022
·
Angelo Roberto Raccagni
, Caterina Candela
, et al.
·
Journal of Infection
·
27
PDF
Prevalence and Risk Factors of Anal HPV Infection in MSM Living With HIV: Identifying the Target Groups to Prioritize for Immunization
2022
·
Elena Bruzzesi
, Laura Galli
, et al.
·
JAIDS Journal of Acquired Immune Deficiency Syndromes
·
23
The evolution of an ancient disease: tuberculosis discoveries in the centuries
2019
·
Riccardi, Niccolò
, Canetti, Diana
, et al.
·
Journal of preventive medicine and hygiene
·
23
PDF
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort
2025
·
Roberta Gagliardini
, Sara De Benedittis
, et al.
·
Journal of Antimicrobial Chemotherapy
·
22
Daptomycin synergistic properties from in vitro and in vivo studies: a systematic review
2022
·
Roberta Maria Antonello
, Diana Canetti
, et al.
·
Journal of Antimicrobial Chemotherapy
·
17
Show more works
View as search
Works count:
98
Citation count:
2,859
H-index:
23
I10-index:
33
Year
Topic
Type